Silverthorne Business Grants

The Comcast Innovation Fund was created to support technology and public policy research that contributes to the betterment of the Internet, and the continued evolution of connectivity products and services. The fund provides grants to technologists, researchers, and academics to support Internet- and connectivity-focused projects within the fund’s areas of interest, which are updated annually.

The FY 2026 National Technical Assistance Programs (NTAP) cooperative agreement supports three national organizations to develop and deliver technical assistance (TA) to existing and potential health centers with a focus on: Supporting the delivery of comprehensive, high-quality primary health care; improving chronic disease management, nutrition, and preventive services; improving operational effectiveness, efficiency, and quality; addressing emergent public health needs and priorities; complying with and exceeding Health Center Program and supplemental funding requirements.

Southern Sustainable Agriculture Research and Education is a U.S. Department of Agriculture program designed to support farmers and ranchers in southern states. Producer Grants are designed to help farmers and ranchers test sustainable agriculture ideas. The annual application process opens in September with grant amounts up to $25,000 awarded the following February.

The Manufacturing 4.0 Technology Investment Program provides grants that assist small- and mid-sized enterprises with the adoption and integration of smart technologies into existing operations in the state. Grants offered through this program are aimed at helping manufacturers increase productivity, efficiency and competitiveness. They may be used for the purchase of equipment and specialized hardware or software in the Industry 4.0 technology groups.

This Notice of Funding Opportunity (NOFO) encourages applications for investigator-initiated, early phase, clinical trials of natural products (i.e., botanicals, probiotics, and products marketed as dietary supplements), which have a strong scientific premise to justify further clinical testing. For this NOFO, natural products include promising nutritional regimens that standardize the amount of a specific naturally occurring nutritional compound (e.g., omega-3 fatty acids, anthocyanidins, or polyphenols) and have compelling preliminary evidence. Under this NOFO, trials must be designed so that results, whether positive or negative, will provide information of high scientific utility and will support decisions about further development or testing of the natural product. This NOFO will provide up to three years (R61 phase) of support for milestone-driven testing of pharmacokinetics, bioavailability, and assessment of the natural products effect (i.e., measure of mechanism of action) when used by humans on a specified target measure. If milestones in the R61 phase are achieved, up to 3 years of additional support (R33 phase) may be awarded to replicate the impact of the natural product on target engagement(s) when used by humans and assess whether there is an association between the degree of the impact on the target engagement and clinical outcomes in a participant population. Applications are encouraged to design R33 studies to determine how to optimize the impact of the natural product on the target engagement by optimizing the delivery of the natural product through examination of different doses or formulations. In addition, applications can be designed to combine the natural product with another treatment approach that is known to impact the same target engagement measure; or study the impact of the natural product in a population that is more responsive,